Michael Rugaard Jensen

1 ta ish

Novartis (Switzerland)

1. Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone

   Paul A. Brough, Xavier Barril, Jenifer Borgognoni +30

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.035864